Prostatype Genomics AB Logo

Prostatype Genomics AB

PROGEN | ST

Overview

Corporate Details

ISIN(s):
SE0022574554 (+2 more)
LEI:
549300JO6MPCGPVHVU91
Country:
Sweden
Address:
Gustav III:s Boulevard 34, 169 73 Solna
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Prostatype Genomics AB offers genomic testing for prostate cancer diagnostics. Their tests support personalized treatment decisions.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Prostatype Genomics AB. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Prostatype Genomics AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Prostatype Genomics AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
genOway Logo genOway France ALGEN
GenSight Biologics S.A. Logo GenSight Biologics S.A. France SIGHT
Gentian Diagnostics ASA Logo Gentian Diagnostics ASA Norway GENT
Genus PLC Logo Genus PLC United Kingdom GNS
Grace Breeding Ltd. Logo Grace Breeding Ltd. Israel GRAC
Group 107 Ltd. Logo Group 107 Ltd. Israel G107
Guard Therapeutics International AB Logo Guard Therapeutics International AB Sweden GUARD
Gubra A/S Logo Gubra A/S Denmark GUBRA
Hadasit Bio Holding Ltd. Logo Hadasit Bio Holding Ltd. Israel HDST-M
Hansa Biopharma Logo Hansa Biopharma Sweden HNSA